11 C-glyburide PET imaging unveils the negligible brain penetration of glyburide in humans - CEA - Commissariat à l’énergie atomique et aux énergies alternatives Accéder directement au contenu
Article Dans Une Revue Neurology Année : 2019

11 C-glyburide PET imaging unveils the negligible brain penetration of glyburide in humans

Résumé

Kimberly and coworkers reported the beneficial effects of intravenous glyburide on the clinical outcome of brain edema. We developed the carbon-11 radiolabeled analogue of glyburide to study the body distribution of this compound using PET imaging. In a healthy subject, the brain distribution of 11C-glyburide matched the cerebral blood volume suggesting negligible blood-brain barrier (BBB) penetration. This clinical observation corroborates preclinical findings suggesting that local changes in BBB structure and function are required for targeted delivery and favorable effects of glyburide to the injured brain tissue while minimizing potential side effects to the healthy brain.

Dates et versions

cea-02160070 , version 1 (19-06-2019)

Identifiants

Citer

Solène Marie, Claude Comtat, Fabien Caillé, Laurent Becquemont, Michel Bottlaender, et al.. 11 C-glyburide PET imaging unveils the negligible brain penetration of glyburide in humans. Neurology, 2019, 92 (17), pp.813-814. ⟨10.1212/WNL.0000000000007378⟩. ⟨cea-02160070⟩
85 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More